Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Summary

This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 for long-term dosing in chronic kidney disease and hyperphosphatemia patients on hemodialysis.

Timeline

Start

2009-05

Primary completion

2010-09

Completion

2010-09

Drugs

Indications